Memorial Sloan Kettering Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
Cabozantinib (XL184) in Patients With Relapsed or Refractory Myeloma
- Conditions
- Relapsed or Refractory Multiple Myeloma
- Interventions
- First Posted Date
- 2013-05-31
- Last Posted Date
- 2017-08-30
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 11
- Registration Number
- NCT01866293
- Locations
- 🇺🇸
Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center at Mercy Medical Center, Rockville Centre, New York, United States
Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma
- Conditions
- Newly Diagnosed Ewing Sarcoma
- Interventions
- Device: DoxorubicinProcedure: SurgeryRadiation: Radiation Therapy*
- First Posted Date
- 2013-05-29
- Last Posted Date
- 2024-11-12
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 83
- Registration Number
- NCT01864109
- Locations
- 🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients
- Conditions
- Breast Cancer
- Interventions
- Procedure: Positron Emission Tomography (PET)Procedure: Positron emission mammography (PEM) When availableProcedure: MR
- First Posted Date
- 2013-05-29
- Last Posted Date
- 2017-08-31
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT01864083
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)
- Conditions
- Cholangiolar CarcinomaCholangiocellular CarcinomaPeripheral CholangiocarcinomaIntrahepatic Cholangiocarcinoma
- Interventions
- Other: MRIOther: Research blood draws
- First Posted Date
- 2013-05-24
- Last Posted Date
- 2025-03-19
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 55
- Registration Number
- NCT01862315
- Locations
- 🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸Memorial Sloan Kettering Nassau, Uniondale, New York, United States
T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
- Conditions
- Relapsed B-Cell Acute Lymphoblastic Leukemia
- Interventions
- Procedure: leukapheresis or collection of PBMCsBiological: modified T cells
- First Posted Date
- 2013-05-23
- Last Posted Date
- 2025-06-05
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 23
- Registration Number
- NCT01860937
- Locations
- 🇺🇸
Dana-Farber Cancer Institute:Dana- Farber/Children's Hospital, Boston, Massachusetts, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy Radiation
- Conditions
- Invasive Breast Cancer
- Interventions
- Other: EucerinOther: Mometasone Furoate 0.1%
- First Posted Date
- 2013-05-17
- Last Posted Date
- 2019-10-03
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 143
- Registration Number
- NCT01856543
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center @ Commack, Commack, New York, United States
🇺🇸Memorial Sloan Kettering West Harrison, Harrison, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma
- Conditions
- Non-Hodgkin's Lymphoma
- Interventions
- Biological: 19-28z T CELLSProcedure: Autologous Stem Cell Transplantation
- First Posted Date
- 2013-04-25
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 17
- Registration Number
- NCT01840566
- Locations
- 🇺🇸
Memorial Sloan Kettering Commack (Limited protocol activities), Commack, New York, United States
🇺🇸Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib
- Conditions
- Hepatocellular Carcinoma
- Interventions
- First Posted Date
- 2013-04-25
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT01840592
- Locations
- 🇺🇸
Memorial Sloan Kettering West Harrison, Harrison, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States
Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive Chemoradiation
- Conditions
- Non-small Cell Lung Cancer
- Interventions
- First Posted Date
- 2013-04-19
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT01836341
Bortezomib in KRAS-Mutant Non-Small Cell Lung Cancer in Never Smokers or Those With KRAS G12D
- First Posted Date
- 2013-04-16
- Last Posted Date
- 2020-08-04
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 17
- Registration Number
- NCT01833143
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center at Mercy Medical Center, Rockville Centre, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States